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Abstract 
Purpose: To examine the protective effect of α-mangostin on Freund’s adjuvant-induced rheumatoid 
arthritis (RA) in rats.  
Methods: Male Wistar rats were divided into four groups (n = 6). The rats were made arthritic using a 
single intradermal injection of 0.1 ml complete Freund's adjuvant. α-Mangostin (100 mg/kg, i.p.) was 
administered for 21 days. After the experimental period, the animals were sacrificed and various 
biochemical markers were assessed. 
Results: Arthritis-induced rats showed a significant (p < 0.05) increase in malondialdehyde (16.28 ± 
1.43 vs 7.22 ± 1.03) and nitric oxide (3.82 ± 0.87 vs 6.12 ± 1.23) with a concomitant reduction of 
antioxidants in the paw tissue. α-Mangostin intervention significantly (p < 0.05) reduced 
malondialdehyde and nitric oxide levels and restored antioxidant levels to normalcy by mitigating 
oxidative stress. The arthritic rats exhibited elevated tumor necrosis factor-α (TNF-α) and interleukin-6 
(IL-6) serum concentrations, upregulated TNF-ߙ and IL–6 protein levels, and upregulated nuclear factor 
 (B) mRNA expression in paw tissues. Treatment with α-mangostin significantly (p < 0.05ߢ-B (NFߢ
reduced serum levels and downregulated inflammatory markers to normalcy.  
Conclusion: The results suggest that α-mangostin displayed a protective effect against adjuvant-
induced arthritis in rats mediated through antioxidant and anti-inflammatory effects. 
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Rheumatoid arthritis (RA) is a chronic 
inflammatory clinical condition characterized by 
neutrophil infiltration in the synovium and 
synovial enlargement. This causes pannus 
formation, which then damages bones and 
cartilage leading to joint malformation [1]. RA 
affects approximately 1 % of the global 
population. RA patients have a decreased quality 
of life due to extended therapy resulting in 
resistance, adverse toxic events, and high 
treatment costs [2]. Many factors are involved in 
RA etiology including genetic predisposition, viral 
and bacterial infections, altered immune status, 
impaired cognitive conditions, sedentary life 
style, and environmental hazards [3]. Reactive 
oxygen species (ROS) generation is also 
implicated in autoimmune diseases because of 
the association between oxidative stress and 
similar diseases [4]. 
 
Mounting evidence suggests that ROS, like 
superoxide and hydroxyl radicals, have a 
predominant role in RA etiology [5]. Furthermore, 
nitric oxide (NO) is a potent reactive nitrogen 
species that interacts with a superoxide radical to 
form a cytotoxic product, peroxynitrite, which 
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eventually causes synovial damage [6]. 
Inflammation then induces joint disease and 
synovial damage. Inflammatory mediators, 
including tumor necrosis factor-alpha (TNF-α) 
and interleukin-6 (IL-6), play a toxic role in RA 
[7]. In addition, a major inflammatory mediator, 
nuclear factor (NF)-κB, is associated with joint 
damage during RA.  
 
Currently, anti-inflammatory drugs such as 
NSAIDs, disease-modifying anti-rheumatic drugs 
(DMARDs), steroid therapy, anti-TNF-α drugs, 
and monoclonal antibodies are the primary 
treatment options for RA [8]. However, usage of 
these drugs is restricted because of their toxic 
effects and high treatment cost. Another 
treatment option is to increase the body’s 
antioxidant supply during free radical encounters 
via antioxidant intake through diet or as a 
supplement.  
 
Alpha-mangostin (α-mangostin) is a therapeutic 
xanthone found in the Garcinia mangostana fruit 
pericarp. It has a high safety rating and is 
effective in the treatment of various pathological 
conditions [9]. Interestingly, earlier reports 
underscore the anti-inflammatory potential of α-
mangostin in an array of preclinical studies [10]. 
Based on the scientific evidence, α-mangostin 
may be an effective therapeutic agent in the 




Αlpha-mangostin and complete Freund’s 
adjuvant (CFA) were procured from Sigma-




Twenty four male Sprague - Dawley rats 
weighing 170- 200 g, were maintained in 
temperature- and humidity-controlled animal 
houses under 12-h light/12-h dark cycle. The 
experimental animals were treated with standard 
diet pellets and water ad libitum. All experiments 
were carried as per the animal care protocol 
approved (ref no. AK3443111) by the Institutional 
Animal Ethics Committee (IAEC) of the 
Department of Orthopaedics, Zhongnan Hospital 
of Wuhan, Wuhan, China, and also complied with 




The animals were randomized into four different 
groups (n = 6) as follows: Group I (Control) - 
received saline (1.5mL/kg, p.o) for 21 days: 
Group 2 (AIA) - CFA - induced arthritis (AIA) for 
21 days; Group 3 (Man) - received α-mangostin 
alone (100mg/kg, p.o.) for 21 days; and Group 4 
(AIA+) - received α-mangostin (100 mg/kg; p.o) 
1hr before complete Freund’s adjuvant injection 
and continued for 21 days. 
 
The animals were made arthritic by a single 
administration of complete Freund’s adjuvant 
(0.1 mL; 10 mg/mL) into the rat hind paw region 
via intra dermal route. 
 
Preparation of tissue homogenate 
 
At the end of the study, the blood was withdrawn 
and collected in heparinised BD vacutainer. Then 
the serum was separated by centrifugation at 
2000 × g for 20 min. The paw tissues were 
quickly removed, washed in ice-cold saline 
stored at –80 oC until required. 
 
Evaluation of antioxidants 
 
SOD level and GSH content in paw tissue 
homogenate were estimated using commercially 
available kits (Nanjing, Jiancheng Co., 
China).The protein content was estimated using 
bovine serum albumin as a standard. 
 
Assessment of lipid peroxidation and nitrite 
 
Malondialdehyde (MDA) is a suitable marker  for 
assessing lipid peroxidation and nitric oxide (NO) 
was measured using the kit supplied by (Nanjing 
Jiancheng Bioengineering Institute, Nanjing, 
Jiangsu Province, China).The protein content 
was estimated using a standard bovine serum 
albumin. 
 
Assay of cytokines 
 
Serum concentrations of IL-6 and TNF-α were 
estimated by ELISA method with a commercial 
kit (ADL Co., San Diego, CA, USA). 
 
Western blot analysis of inflammatory 
proteins 
 
Extraction of paw tissue proteins was done using 
RIPA lysis buffer kit (Applygen Technologies Inc., 
China). Then the protein samples (20 µg) were 
resolved by 10 % sodiumdodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) 
Rabbit anti - IL - 6 and rabbit anti – TNF - α (1 : 
400) were used as the primary standards. After 
washing, the blot was incubated with a 
secondary antibody, goat anti-mouse IgG 
conjugated to peroxidase (Santa Cruz, USA). 
The antigen- antibody reaction was estimated by 
ECL detection kit (Applygen Technologies Inc, 
China) and the protein bands were observed by 
Gel Doc XR system (Bio-Rad, USA). 
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RT-PCR analysis of NF-κB 
 
From the frozen paw tissue sample the RNA was 
isolated and purified using RNAase (Sigma, 
USA) as per manufacturer’s instruction. The 
cDNAs was prepared using 1μg of the purified 
RNA sample. The oligonucleotide primers used 
in the study were as follows: NF- κB (P65)(381 
bp):5′ CCT ATC CAC GAC AAC CTT GC 3′ 
(forward),5′CAT AGA TGC TGC TGA CCC AAC 
3′ (reverse);β - actin (493 bp):5′-GTG GGGCGC 
CCA GGC ACC A-3′ (forward) and 5′-GCT CGG 
CCG TGGTGG TGA AGC-3′ (reverse).The 
reaction was carried out for  30 cycles as follows: 
30s denaturing at 95 °C followed by a 30-
sannealing step at 57 °C. Finally the extension 
step was carried out for 1 min at 72 °C. The 
protein band density value using the digital 




The data are presented as mean ± SD (standard 
deviation). Differences between the groups were 
analyzed by one-way analysis of variance 
(ANOVA) followed by Tukey’s test to assess the 
significance. P < 0.05 was taken as statistically 
significant. SPSS software, version 13, was used 




In the arthritis group, the malondialdehyde (MDA) 
level and NO was higher (p < 0.05) than in the 
control rats. α-Mangostin treatment significantly 
reduced the MDA and NO level and thus 
inhibited the oxidative stress (Figure 1). 
 
In the arthritis condition, the SOD, GPx, and 
GSH levels were significantly (p < 0.05) 
decreased in arthritic rats compared with the 
control rats. However, treatment with α-
mangostin significantly boosted the antioxidant 
levels to normalcy (Figure 2). In the present 
study, the serum concentration of IL-6 and TNF-
α were significantly (p < 0.05) elevated in the 
arthritis group. Treatment with α-mangostin 
significantly (p < 0.05) decreased the cytokine 
levels mediated through its anti-inflammatory 
effect (Figure 3). 
 
Figure 1: Effect of α-mangostin and AIA on MDA level (A) and NO (B) in paw tissue. Values are expressed as 
mean ± S.D. for six rats in each group. Comparisons between control and (a) AIA; (b) AIA + α-mangostin; 
*statistically significant (p < 0.05); AIA, adjuvant-induced arthritis 
 
 
Figure 2: Effect of α-mangostin and AIA on antioxidant levels in paw tissue. (A) SOD (U/mg protein); (B) GSH 
(µg/mg protein). Values are expressed as mean ± S.D. for six rats in each group. Comparisons between control 
and (a) AIA; (b) AIA + α-mangostin; *statistically significant (p < 0.05); AIA, adjuvant-induced arthritis 
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Figure 3: Pro-inflammatory cytokine levels in serum. (A) TNF-α (pg/mL); (B) IL-6 (pg/mL). Values are expressed 
as mean ± S.D. for six rats in each group. Comparisons between control and (a) AIA; (b) AIA + α-mangostin; 
*statistically significant (p < 0.05); AIA, adjuvant-induced arthritis 
 
 
Figure 4: Western blot analysis of pro-inflammatory cytokines in paw tissues. (A) AIA rats displayed upregulated 
TNF-α and IL-6 expression whereas α-mangostin treatment downregulated the expression to normalcy. (B) 
Relative expression of pro-inflammatory cytokines (TNF-α and IL-6). Values are expressed as mean ± SD (n = 6); 
comparisons between control and (a) AIA; (b) AIA + α-mangostin; *statistically significant (p < 0.05); AIA, 
adjuvant-induced arthritis 
 
The arthritic rats displayed upregulated IL-6 and 
TNF–α protein levels in paw tissue. However, 
compared with the arthritis group, treatment with 
α-mangostin attenuated the IL-6 and TNF-α level 
in the paw tissue (Figure 4). The relative 
expression of IL-6 and TNF-α were significantly 
(p < 0.05) higher in the arthritis group than the 
control. The arthritic rats treated with α-
mangostin showed a significant (p < 0.05) 
decrease in the protein level of the pro-
inflammatory cytokines (Figure 4). 
 
There was a significant increase in NF-κB 
expression in the paw tissue samples from 
arthritis-induced rats. However, therapeutic 
intervention using α-mangostin significantly 
reduced the levels NF-κB mRNA expression in 
the paw tissues (Figure 5A). The relative NF-κB 
mRNA expression level showed a significant (p < 
0.05) increase in the arthritis group. The arthritic 
rats treated with α-mangostin showed 




Figure 5: Effect of α-mangostin and AIA on RT–PCR 
analysis of NF-κB mRNA expression in paw tissues. 
(A): In AIA rats, upregulated mRNA expression of NF-
κB was observed and α-mangostin treatment 
attenuated the inflammation by downregulating NF-κB 
expression. (B) Relative NF-κB mRNA expression. 
Values are expressed as mean ± SD (n = 6); 
comparison between control and (a) AIA; (b) AIA + α-
mangostin; *statistically significant (p < 0.05). AIA, 
adjuvant-induced arthritis 
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Many preclinical reports substantiate that free 
radical stress has a prime role in the etiology of 
RA [12,13]. The generated ROS alters important 
cellular organs and forcefully damages the DNA, 
proteins, and lipids. During RA, the free radicals 
such as hydroxy radical, peroxynitrile, and 
hydrogen peroxide alter the lipid membrane 
structures and cause functional impairment of 
cellular components [14]. Lipid peroxidation is 
the key noxious event involved in RA [15]. 
 
 
MDA, a by-product from lipid peroxidation, 
attacks the lipid structures in cellular membranes 
and thus acts as reliable biological marker for 
free radical damage. MDA is a reactive molecule 
formed during the peroxidation of 
polyunsaturated fatty acids in the cell membrane 
[16]. In this study, an increased MDA level was 
observed in the paw tissue homogenate from 
arthritic rats, which is line with previous 
preclinical reports [17].  
 
In this study, α-mangostin treatment significantly 
reduced the increased MDA level to normalcy. 
Phenolic and phenolic compounds exhibit their 
biological action by free radical scavenging [18] 
and inhibition of lipid peroxidative chains. The 
free radical scavenging potential of phenolic 
compounds is due to the presence of a hydroxyl 
and phenoxy functional group, which has the 
ability to donate the lone pair of electrons. The 
resultant phenolic radical converts to a 
quininemethide intermediate and is 
biotransformed via bile [19]. The effect of α-
mangostin on lipid peroxidation inhibition is due 
to its phenolic-like anti-oxidant property. 
 
The human biological system encompasses a 
battery of antioxidant molecules to counter the 
free radical attack during RA [20]. The 
antioxidant defense mechanism against oxidative 
stress is initiated by SOD. During the oxidative 
stress pathway, the superoxide radical is 
released and the catalytic action of catalase 
converts GPx to H2O2 and molecular oxygen. 
Due to this reaction, vital biological organs and 
tissues are damaged from the decreased 
antioxidant levels. Finally, GSH counteracts the 
free radicals by quenching the single oxygen and 
hydroxide thereby protecting the tissues and 
organs [21]. Thus, in the present study, treatment 
with α-mangostin effectively reduced oxidative 
stress and significantly elevated the depleted 
level of both enzymatic and non-enzymatic 
antioxidants. Earlier work underscores the α-
mangostin efficacy on inflammatory conditions in 
a murine model in relation to oxidative stress 
[22]. 
 
TNF-ߙ and IL-6 are pro-inflammatory cytokines 
with a crucial role in the development of RA. 
Early phase elevated TNF-ߙ and IL-6 serum 
levels are the hallmark of RA [23]. In the present 
investigation, treatment with α-mangostin 
significantly downregulated TNF-α and IL-6 
serum protein expression and upregulated paw 
tissue expression, which corroborates previous 
reports [24]. 
 
NF-ߢB is a key protein that mediates the 
inflammatory reaction during RA. NF-ߢB can 
induce pro-inflammatory cytokines, such as TNF-
 and IL-6, which can increase RA inflammation ߙ
[25]. In this study, the elevated NF-κB mRNA 
level in arthritis-induced paw tissue was 
demonstrated. However, treatment with α-
mangostin down regulated NF-κB mRNA 
expression, and thus inhibited the generation of 
an inflammatory mediator leading to the 




α-Mangostin treatment significantly attenuates 
oxidative stress and inflammation in arthritic rats 
and is therefore potentially an alternative 
treatment for RA. However, further molecular 
studies are highly are required to elucidate the 
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